Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Profit After Tax (2018 - 2025)

Dna X (SONM) has disclosed Profit After Tax for 8 consecutive years, with -$4.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Profit After Tax fell 89.21% year-over-year to -$4.8 million, compared with a TTM value of -$33.4 million through Sep 2025, down 149.38%, and an annual FY2024 reading of -$33.6 million, down 37286.67% over the prior year.
  • Profit After Tax was -$4.8 million for Q3 2025 at Dna X, up from -$7.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $527000.0 in Q3 2023 and bottomed at -$21.6 million in Q4 2024.
  • Average Profit After Tax over 5 years is -$5.2 million, with a median of -$4.2 million recorded in 2022.
  • The sharpest move saw Profit After Tax soared 132.77% in 2023, then crashed 1497.49% in 2024.
  • Year by year, Profit After Tax stood at -$11.7 million in 2021, then skyrocketed by 91.11% to -$1.0 million in 2022, then fell by 29.85% to -$1.4 million in 2023, then plummeted by 1497.49% to -$21.6 million in 2024, then skyrocketed by 78.01% to -$4.8 million in 2025.
  • Business Quant data shows Profit After Tax for SONM at -$4.8 million in Q3 2025, -$7.5 million in Q2 2025, and $458000.0 in Q1 2025.